HIGHLIGHTS
- who: Thore Buergel from the Center for DigitalUniversity of Glasgow, Glasgow, UK have published the research work: Metabolomic profiles predict individual multidisease outcomes, in the Journal: (JOURNAL) of 28/07/2022
- what: Subsequently the authors focused on T2D (Fig 5b) and all-cause dementia (Fig 5c) two diseases with strong contributions over the comprehensive clinical predictors and indications of clinical utility (see above). Taken together the work demonstrates the potential and limitations of NMR-derived as a multidisease assay to inform on the risk of many common diseases simultaneously.
SUMMARY
Received . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.